Literature DB >> 25609817

Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Atsushi Kobayashi1, Piero Parchi2, Masahito Yamada3, Paul Brown4, Daniela Saverioni5, Yuichi Matsuura6, Atsuko Takeuchi1, Shirou Mohri1, Tetsuyuki Kitamoto7.   

Abstract

UNLABELLED: The genotype at polymorphic codon 129 of the PRNP gene has a profound influence on both phenotypic expression and prion strain susceptibility in humans. For example, while the most common sporadic Creutzfeldt-Jakob disease (CJD) subtype, sporadic CJD-MM1 (M1 strain), induces a single phenotype after experimental transmission regardless of the codon 129 genotype of the recipient animal, the phenotype elicited by sporadic CJD-VV2 (V2 strain), the second most common subtype, varies according to the host codon 129 genotype. In particular, the propagation of the V2 strain in codon 129 methionine homozygotes has been linked only to acquired forms of CJD such as plaque-type dura mater graft-associated CJD (dCJD), a subgroup of iatrogenic CJD with distinctive phenotypic features, but has never been observed in sporadic CJD cases. In the present report, we describe atypical CJD cases carrying codon 129 methionine homozygosity, in a neurosurgeon and in a patient with a medical history of neurosurgery without dural grafting, showing the distinctive phenotypic features and transmission properties of plaque-type dCJD. These findings raise the possibility that the two cases, previously thought to represent sporadic CJD, might actually represent acquired CJD caused by infection with the V2 strain. Thus, careful analyses of phenotypic features and transmission properties in atypical cases may be useful to distinguish acquired from sporadic cases of CJD. IMPORTANCE: Susceptibility to and phenotypic expression of Creutzfeldt-Jakob disease (CJD) depend on both the prion strain and genotype at polymorphic codon 129 of the PRNP gene. For example, propagation of the second most common sporadic CJD strain (V2 strain) into codon 129 methionine homozygotes has been linked to plaque-type dura mater graft-associated CJD (dCJD), a subgroup of iatrogenic CJD with distinctive phenotypic features, but has never been observed in sporadic CJD. In the present report, we describe atypical CJD cases in a neurosurgeon and in a patient with a medical history of neurosurgery without dural grafting, showing the distinctive phenotypic features and transmission properties of plaque-type dCJD. These findings raise the possibility that the two cases, previously considered to represent sporadic CJD, might actually represent acquired CJD caused by infection with the V2 strain.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25609817      PMCID: PMC4403436          DOI: 10.1128/JVI.03183-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

3.  Prospective 10-year surveillance of human prion diseases in Japan.

Authors:  Ichiro Nozaki; Tsuyoshi Hamaguchi; Nobuo Sanjo; Moeko Noguchi-Shinohara; Kenji Sakai; Yosikazu Nakamura; Takeshi Sato; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Fumio Moriwaka; Yusei Shiga; Yoshiyuki Kuroiwa; Masatoyo Nishizawa; Shigeki Kuzuhara; Takashi Inuzuka; Masatoshi Takeda; Shigetoshi Kuroda; Koji Abe; Hiroyuki Murai; Shigeo Murayama; Jun Tateishi; Ichiro Takumi; Susumu Shirabe; Masafumi Harada; Atsuko Sadakane; Masahito Yamada
Journal:  Brain       Date:  2010-09-20       Impact factor: 13.501

Review 4.  Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.

Authors:  Piero Parchi; Rosaria Strammiello; Armin Giese; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2010-11-24       Impact factor: 17.088

5.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.

Authors:  Masahito Yamada; Moeko Noguchi-Shinohara; Tsuyoshi Hamaguchi; Ichiro Nozaki; Tetsuyuki Kitamoto; Takeshi Sato; Yosikazu Nakamura; Hidehiro Mizusawa
Journal:  Neuropathology       Date:  2009-07-29       Impact factor: 1.906

7.  A traceback phenomenon can reveal the origin of prion infection.

Authors:  Atsushi Kobayashi; Masahiro Asano; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Neuropathology       Date:  2009-07-29       Impact factor: 1.906

8.  Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.

Authors:  M Noguchi-Shinohara; T Hamaguchi; T Kitamoto; T Sato; Y Nakamura; H Mizusawa; M Yamada
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

9.  Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008.

Authors:  Tsuyoshi Hamaguchi; Moeko Noguchi-Shinohara; Ichiro Nozaki; Yosikazu Nakamura; Takeshi Sato; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Masahito Yamada
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  vCJD prion acquires altered virulence through trans-species infection.

Authors:  Masahiro Asano; Shirou Mohri; James W Ironside; Mamoru Ito; Norikazu Tamaoki; Tetsuyuki Kitamoto
Journal:  Biochem Biophys Res Commun       Date:  2006-02-07       Impact factor: 3.575

View more
  13 in total

1.  Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Masanori Morita; Shusei Uno; Tetsuyuki Kitamoto
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

Review 2.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 4.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

5.  Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Authors:  Ignazio Cali; Mark L Cohen; Stephane Haik; Piero Parchi; Giorgio Giaccone; Steven J Collins; Diane Kofskey; Han Wang; Catriona A McLean; Jean-Philippe Brandel; Nicolas Privat; Véronique Sazdovitch; Charles Duyckaerts; Tetsuyuki Kitamoto; Ermias D Belay; Ryan A Maddox; Fabrizio Tagliavini; Maurizio Pocchiari; Ellen Leschek; Brian S Appleby; Jiri G Safar; Lawrence B Schonberger; Pierluigi Gambetti
Journal:  Acta Neuropathol Commun       Date:  2018-01-08       Impact factor: 7.801

6.  Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.

Authors:  Marcello Rossi; Daniela Saverioni; Michele Di Bari; Simone Baiardi; Afina Willemina Lemstra; Laura Pirisinu; Sabina Capellari; Annemieke Rozemuller; Romolo Nonno; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2017-11-23       Impact factor: 7.801

7.  UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.

Authors:  Diane L Ritchie; Marcelo A Barria; Alexander H Peden; Helen M Yull; James Kirkpatrick; Peter Adlard; James W Ironside; Mark W Head
Journal:  Acta Neuropathol       Date:  2016-11-03       Impact factor: 17.088

Review 8.  Prion disease: experimental models and reality.

Authors:  Sebastian Brandner; Zane Jaunmuktane
Journal:  Acta Neuropathol       Date:  2017-01-13       Impact factor: 17.088

9.  Rapidly Progressing Sporadic Creutzfeldt-Jakob Disease Presenting as a Stroke.

Authors:  Maxim Oliver; Lisa Dyke; Alex Rico; Mario Madruga; Jorge Parellada; Steve J Carlan
Journal:  Case Rep Neurol       Date:  2018-09-13

10.  The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.

Authors:  Roger A Moore; Mark W Head; James W Ironside; Diane L Ritchie; Gianluigi Zanusso; Young Pyo Choi; Young Pyo Choi; Suzette A Priola
Journal:  PLoS Pathog       Date:  2016-02-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.